Goodbye to bells and whistles - low cost rules

摘要

What do mounting cost pressures within the pharmaceutical sector mean for the machinery sector? Andrew Manly examines the trends. A new culture of low cost sourcing for pharmaceutical equipment seems to be upon us. The days of pharmaceutical companies buying the best technology available with all the 'bells and whistles' is over. Loyalty to a particular supplier has also "gone out of the window", according to many suppliers. Tendering is now fiercer than it has ever been and issues such as Total Cost of Ownership (TCO) are major factors in purchasing decisions.